Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression [Phase 3]
Phase 3 clinical trial evaluating psilocybin for treatment-resistant major depression in veterans is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners [NA]
Massachusetts General Hospital is conducting a clinical trial to test a behavioral health program for short-stay nursing facility residents …
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Social Needs Screening and Chronic Diseases Study (WE CARE) [NA]
This clinical trial update describes the WE CARE study on social needs screening and chronic diseases, sponsored by the University of Massac…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Transcranial Direct Current Stimulation for Depression [NA]
Soterix Medical is recruiting for a clinical trial evaluating transcranial direct current stimulation as a treatment for major depressive di…
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals’ supplemental application for Bupropion Hydrochloride (SR). The approval updates the labeling for the s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride (generic) from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals …
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for a generic bupropion hydrochloride product by Alembic Pharmaceuticals Limited.
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma, Inc., establishing a generic sustained-release f…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy [Phase 3]
Phase 3 study evaluating aticaprant as an adjunctive therapy for adults with major depressive disorder and moderate-to-severe anhedonia; the…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD [Phase 3]
A randomized, double-blind, placebo-controlled Phase 3 trial of REL-1017 as an adjunctive treatment for Major Depressive Disorder has been t…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Comparing Individual Therapies for Veterans With Depression, PTSD, and Panic Disorder [NA]
VA-sponsored clinical trial comparing individual therapies for veterans with major depressive disorder, posttraumatic stress disorder, and p…
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (CIPLA USA INC.,)
FDA approved a supplemental application for bupropion hydrochloride from CIPLA USA INC., under the generic drug approval pathway.
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: A Tailored and Digital Approach to Address Equity and Support Well-being for Healthcare Workers in the Era of COVID [NA]
This clinical trial update describes a tailored digital program aimed at promoting equity and well-being among healthcare workers during COV…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) [Phase 3]
A Phase 3 clinical trial evaluating REL-1017 as an adjunctive treatment for Major Depressive Disorder has been terminated, according to the …
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Treating Major Depression With Yoga Mono-therapy [NA]
A University of California, San Francisco trial is evaluating yoga as mono-therapy for mild-to-moderate major depressive disorder and is cur…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury [NA]
A clinical trial update describes development of a digital intervention for adolescents with nonsuicidal self-injury, depression, and anxiet…
-
FDA approval · 2025-11-05FDA Approved: AUVELITY — Supplemental Application (Axsome Therapeutics, Inc.)
The FDA approved a supplemental application for AUVELITY, the fixed-dose combination of dextromethorphan hydrobromide and bupropion hydrochl…
-
FDA approval · 2025-11-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Bupropion hydrochloride from Aurobindo Pharma Limited, approving a new generic form of the antid…
-
FDA approval · 2025-11-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Bupropion Hydrochloride from BluePoint Laboratories. This action updates the approved generi…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Digital Intervention to Treat Anxiety and Depression Among Persons Receiving Treatment for Opioid Use Disorder [NA]
A completed clinical trial assessed a digital intervention to treat anxiety and depression in people undergoing treatment for opioid use dis…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Improving Outcomes in Depression in Primary Care in a Low Resource Setting [Phase 3]
A Phase 3 clinical trial in primary care settings in a low-resource environment aims to improve outcomes for patients with major depressive …
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Evaluation of Teen Connection Project for Trans and Gender Minority Youth [NA]
Completed clinical trial by the University of Michigan evaluating the Teen Connection Project for transgender and gender minority youth, foc…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Mood and Thought Process Study [NA]
A Butler Hospital-sponsored mood and thought process study is recruiting participants for depression-related conditions, including depressio…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty [NA]
A clinical trial update indicates RXWell is recruiting to test whether it can decrease post-operative opioid use in patients undergoing tota…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Electronic Media and Its Application in Psychotherapy [NA]
A clinical trial conducted by McLean Hospital evaluating electronic media in psychotherapy for anxiety disorders and depression has complete…